So as to be a fully integrated pharmaceutical manufacturing company, Parabolic Drugs has entered the dosage space with an aim to make Rs 150 crore by way of sales within 3-5 years, said director Vineet Gupta.
To begin with, the company is focusing on India and a few international markets.Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
